1. Center for the Study of Tobacco Products
  2. Policy Research

Policy Research

Overview

With the proliferation of potential modified risk tobacco products and other novel (non-cigarette) tobacco products, policymakers in the U.S. and abroad require evidence to inform effective regulatory strategies and set priorities for tobacco control. Policy research being conducted at VCU’s Center for the Study of Tobacco Products (CSTP) informs a broad array of stakeholders including state and local governments in Virginia, the U.S. Food and Drug Administration, and the U.S. Surgeon General. 

VCU’s CSTP engages in global tobacco policy research. Locally, the VCU CSTP is curating a series of policy briefs aimed at informing state and local legislation on potential modified risk tobacco products and other novel tobacco products in the Commonwealth of Virginia. These exemplars of the VCU CTSP’s ongoing policy research are described in more detail below.

VCU’s CSTP Policy Brief Series

With youth and young adults in Virginia becoming increasingly more likely to use non-cigarette tobacco products, like electronic cigarettes, decision-makers in the Commonwealth need access to timely and reliable evidence tailored for them to inform tobacco prevention and control policies. VCU’s Center for the Study of Tobacco Products’ policy brief series provides this important information.

The briefs in the series, “The State of Hookah Smoking and Tobacco Control Policy in Virginia,” and “Surveying the Policy Environment for E-cigarettes in Virginia,” are available below. New briefs on emerging issues in potential modified risk tobacco products and other novel (non-cigarette) tobacco products are released every few months.

If you would like to see a specific policy or topic related to novel tobacco products addressed in an upcoming brief, please contact Andrew J. Barnes, Ph.D. at abarnes3@vcu.edu.

This research is supported by the National Institute on Drug Abuse of the National Institutes of Health and the Center for Tobacco Products of the U.S. Food and Drug Administration under Award Number U54DA036105. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or the Food and Drug Administration